Atoxia 60mg contains Etoricoxib, a selective COX-2 inhibitor (NSAID) manufactured by United Pharmaceuticals. It is indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and chronic musculoskeletal pain.
As a selective COX-2 inhibitor, Etoricoxib provides effective anti-inflammatory and analgesic action with a reduced risk of gastrointestinal side effects compared to non-selective NSAIDs. The 60mg dose is suitable for long-term management of chronic inflammatory conditions.
Important: Use only as directed by your healthcare professional. Read the patient information leaflet before use.
Actual product packaging and materials may contain more and different information than what is shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

← this is the last line of the file